另外，在非肿瘤治疗领域，随着从分子生物学角度更好的理解疾病，对于特定靶点药物的研究有所增加。
Also, in nononcologic therapeutic areas understanding the molecular biology of the disease increases; thus, the chances of developing specific targeted drugs increase.
而弄清楚这些分子的结构有助于科学家们去研究那些由畸形蛋白质引起的疾病，并找出更好的药物靶点。
Figuring out such structures could help scientists learn more about diseases caused by malformed proteins and identify better drug targets.
新的药物以各种分子过程为靶点，但它们常常只对某个特定癌症的一群人有效。
New drugs target a variety of these cellular processes, but they will often only be effective in a subset of patients according to the profile of their particular cancer.
应用推荐